Psychedelics Archives - Page 3 of 6 - Reason Foundation

Ibogaine treatment for opioid use disorder

Policy Brief by Madison Carlino

Regulated psilocybin access in Arizona would help treat mental health conditions

Backgrounder by Leonard Gilroy and Geoffrey Lawrence

Nonprofit announces new partnership with Ohio to tackle opioid addiction with ibogaine

Commentary by Gregory Ferenstein and Leonard Gilroy

A policy framework for personal psychedelics licenses

Policy Brief by Gregory Ferenstein

Psychedelics Policy Newsletter: Impactful ibogaine study, bill introduced in New Hampshire, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics policy roundup: January 2024 edition

Commentary by Gregory Ferenstein

New Hampshire proposes a unique approach to medical psychedelics

Commentary by Gregory Ferenstein

New study of psychedelic ibogaine could motivate policy reforms

Commentary by Gregory Ferenstein and Geoffrey Lawrence

Psychedelics Policy Newsletter: California’s steps after bill vetoed, Kentucky ibogaine funds, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

More Psychedelics